Complications of surgery and chemotherapy for testicular cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 6, 2005, Pages 447-455

  Abouassaly, Robert ^a   Klein, Eric A ^a   Raghavan, Derek ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Fertility; Pulmonary; Surgery; Toxicity; Vascular

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; VINBLASTINE; VINCA ALKALOID;

AUTONOMIC NEUROPATHY; BILE DUCT INJURY; CANCER CHEMOTHERAPY; CANCER SURGERY; CEREBROVASCULAR DISEASE; CHYLOUS ASCITES; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DEPRESSION; DUODENUM INJURY; EJACULATION DISORDER; HEARING IMPAIRMENT; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOMAGNESEMIA; IATROGENIC DISEASE; INFERTILITY; INTESTINE VOLVULUS; KIDNEY FAILURE; LEUKEMIA; LUNG EMBOLISM; LUNG FIBROSIS; LUNG TOXICITY; LYMPHOCELE; METASTASIS; NEPHRITIS; NEPHROTOXICITY; NERVE INJURY; NEUROTOXICITY; OSTEOPOROSIS; PARAPLEGIA; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RAYNAUD PHENOMENON; RENOVASCULAR DISEASE; SMALL INTESTINE OBSTRUCTION; SPINAL CORD ISCHEMIA; TESTIS CANCER; TINNITUS; URETER INJURY; URETHRA STRICTURE; VEIN THROMBOSIS; WOUND INFECTION;

DRUG THERAPY; HUMANS; INFERTILITY, MALE; LYMPH NODES; MALE; QUALITY OF LIFE; TESTICULAR NEOPLASMS;

EID: 27844538757     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.06.006     Document Type: Conference Paper

References (69)

1. L.H. Einhorn, J.P. Donohue Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87 1977 293 298
2. R. Bihrle, J.P. Donohue, R.S. Foster Complications of retroperitoneal lymph node dissection Urol Clin North Am 15 1988 237 242
3. J. Baniel, R.S. Foster, R.G. Rowland Complications of primary retroperitoneal lymph node dissection J Urol 152 1994 424 427
4. J. Baniel, R.S. Foster, R.G. Rowland Complications of post-chemotherapy retroperitoneal lymph node dissection J Urol 153 1995 976 980
5. J.J. Rassweiler, T. Frede, E. Lenz Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer Eur Urol 27 2000 251 260
6. M.A.S. Jewett, T. Wesley-James Early and late complications of retroperitoneal lymphadenectomy in testis cancer Can J Surg 34 1991 368 373
7. J.R. Spermon, T.A. Roeleveld, H.G. VanderPoel Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumors Urology 59 2002 923 929
8. A. Heidenreich, P. Albers, M. Hartmann Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis Experience of the German testicular cancer study group J Urol 169 2003 1710 1714
9. J.M. McKiernan, R.J. Motzer, D.F. Bajorin Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor Clinical presentation, patterns of recurrence, and outcome Urology 62 2003 732 736
10. A.A. Mosharafa, R.S. Foster, M.O. Koch Complications of post-chemotherapy lymph node dissection for testis cancer J Urol 171 2004 1839 1841
11. D.G. Skinner, A. Melamud, G. Leikovsky Complications of thoracoabdominal retroperitoneal lymph node dissection J Urol 127 1982 1107 1110
12. R.J. Babaian, R.B. Bracken, D.E. Johnson Complications of retroperitoneal lymphadenectomy Urology 17 1981 126 128
13. P.H. Beck, R.E. Stutzman Complications of retroperitoneal lymphadenectomy for nonseminomatous tumors of testis Urology 13 1979 244 247
14. J. Baniel, A. Sella Complications of retroperitoneal lymph node dissection in testicular cancer primary and post-chemotherapy Semin Surg Oncol 17 1999 263 267
15. J. Baniel, R.S. Foster, R.G. Rowland Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer J Urol 150 1993 1422 1424
16. S.A. Haukaas, L. Daehlin, N.M. Ulvik Surgical management of chylous fistula after retroperitoneal lymph node dissection Scand J Urol Nephrol 33 1999 71 72
17. J.P. Donohue, J.A. Thornhill, R.S. Foster Vascular considerations in postchemotherapy retroperitoneal lymph node dissection Part I-Vena cava World J Urol 12 1994 182 186
18. T.J. Christmas, G.L. Smith, R. Kooner Vascular interventions during post-chemotherapy retroperitoneal lymph node dissection for metastatic testis cancer Eur J Surg Oncol 24 1998 292 297
19. J.P. Donohue, R.G. Rowland Complications of retroperitoneal lymph node dissection J Urol 125 1981 338 340
20. I. Leibovitch, P.A. Nash, J.S. Little Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer J Urol 155 1996 947 951
21. H. Steiner, R. Peschel, G. Janetschek Long-term results of laparoscopic retroperitoneal lymph node dissection A single-center 10-year experience Urology 63 2004 550 555
22. J.R. Spermon, L.A. Kiemeney, E.J.H. Meuleman Fertility in men with testicular germ cell tumors Fertil Steril 79 2003 1543 1549
23. E. Huyghe, T. Matsuda, M. Daudin Fertility after testicular cancer treatments Results of a large multicenter study Cancer 100 2004 732 737
24. P. Alberts, D. Melchior, S.C. Muller Surgery in metastatic testicular cancer Eur Urol 44 2003 233 244
25. A. Spitz, T.G. Wilson, M.H. Kawachi Vena caval resection for bulky metastatic germ cell tumors An 18-year experience J Urol 158 1997 1813 1818
26. S.D. Beck, S.G. Lalka Long-term results after inferior vena caval resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer J Vasc Surg 28 1998 808 814
27. A. Hobisch, J. Tonnemann, G. Janetschek Morbidity and quality of life after open versus laparoscopic retroperitoneal lymphadenectomy for testicular tumor - The patient's view W.G. Jones I. Appleyard P. Harnden Germ Cell Tumours VI 1998 John Libbey London (UK) 277 280
28. L.H. Einhorn Testicular cancer as a model for a curable neoplasm The Richard and Hinda Rosenthal Foundation Award Lecture Cancer Res 41 1981 3274 3280
29. J.A. Levi, D. Thomson, T. Sandeman A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy Role of maintenance and long-term follow-up J Clin Oncol 6 1988 1154 1160
30. J.A. Levi, D. Raghavan, V. Harvey The importance of bleomycin in combination chemotherapy for good prognosis germ cell carcinoma J Clin Oncol 11 1993 1300 1305
31. R. de Wit, G. Stoter, S.B. Kaye Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group J Clin Oncol 15 1997 1837 1843
32. P.J. Loehrer Sr, D. Johnson, P. Elson Importance of bleomycin in favorable-prognosis disseminated germ cell tumors An Eastern Cooperative Oncology Group trial J Clin Oncol 13 1995 470 476
33. J.L. Jensen, R. Goel, P.M. Venner The effect of corticosteroid administration on bleomycin lung toxicity Cancer 65 1990 1291 1297
34. M. Dentino, F.C. Luft, M.N. Yum Long term effect of cis- diamminodichloride platinum (CDDP) on renal function and structure in man Cancer 41 1978 1274 1281
35. P. Fjeldborg, J. Sorensen, P.E. Helkjaer The long-term effect of cisplatin on renal function Cancer 58 1986 2214 2217
36. S. Meijer, D.T. Sleijfer, N.H. Mulder Some effects of combination chemotherapy with cis-platinum on renal function in patients with non-seminomatous testicular carcinoma Cancer 51 1983 2035 2040
37. S.W. Hansen, S. Groth, G. Daugaard Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer J Clin Oncol 6 1988 1728 1731
38. S.D. Fossa, N. Aass, M. Winderen Long-term renal function after treatment for malignant germ-cell tumours Ann Oncol 13 2002 222 228
39. M.J. Boyer, D. Raghavan, P.J. Harris Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer J Clin Oncol 8 1990 21 26
40. J.T. Hartmann, C. Kollmannsberger, L. Kanz Platinum organ toxicity and possible prevention in patients with testicular cancer Int J Cancer 83 1999 866 869
41. D. Adoue, P. Arlett Bleomycin and Raynaud's phenomenon Ann Intern Med 100 1984 770
42. N.J. Vogelzang, G.J. Bosl, K. Johnson Raynaud's phenomenon A common toxicity after combination chemotherapy for testicular cancer Ann Intern Med 95 1981 288 292
43. S.W. Hansen, N. Olsen Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer Measurement of vasoconstrictor response to cold J Clin Oncol 7 1989 940 942
44. B.J. Roth, A. Greist, P.S. Kubilis Cisplatin-based combination chemotherapy for disseminated germ cell tumors Long-term follow-up J Clin Oncol 6 1988 1239 1247
45. D. Raghavan, K. Cox, A. Childs Hypercholesterolemia after chemotherapy for testis cancer J Clin Oncol 10 1992 1386 1389
46. J.A. Gietema, D.T. Sleijfer, P.H.B. Willemse Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer Ann Intern Med 116 1992 709 715
47. P.A. Ellis, B.M. Fitzharris, P.M. George Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors J Clin Oncol 10 1992 1609 1614
48. J. Nuver, A.J. Smit, B.H.R. Wolffenbuttel The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer J Clin Oncol 23 2005 3718 3725
49. A. Hantel, E.K. Rowinsky, R.C. Donehower Nifedipine and oncologic Raynaud phenomenon Ann Intern Med 108 1988 767
50. D.C. Doll, A.F. List, F.A. Greco Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis Ann Intern Med 105 1986 48 51
51. B.M. Cantwell, K.A. Mannix, J.T. Roberts Thromboembolic events during combination chemotherapy for germ cell-malignancy Lancet 2 1988 1086 1087
52. N.J. Vogelzang, D.H. Frenning, B.J. Kennedy Coronary artery disease after treatment with bleomycin and vinblastine Cancer Treat Rep 64 1980 1159 1160
53. J.A. Gietema, M.T. Meinardi, J. Messerschmidt Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer Lancet 355 2000 1075 1076
54. M.T. Meinardi, J.A. Gietema, W.T. van der Graaf Cardiovascular morbidity in long-term survivors of metastatic testicular cancer J Clin Oncol 18 2000 1725 1732
55. S.D. Williams, R. Birch, L.H. Einhorn Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide N Engl J Med 316 1987 1435 1440
56. C. Bokemeyer, C.C. Berger, M.A. Kuczyk Evaluation of long-term toxicity after chemotherapy for testicular cancer J Clin Oncol 14 1996 2923 2932
57. R.R. Reddel, R.F. Kefford, J.M. Grant Ototoxicity in patients receiving cisplatin Importance of dose and method of drug administration Cancer Treat Rep 66 1982 19 23
58. L.B. Travis, R.E. Curtis, H. Storm Risk of second malignant neoplasms among long-term survivors of testicular cancer J Natl Cancer Inst 89 1997 1429 1439
59. F.E. van Leeuwen, A.M. Stiggelbout, A.W. van den Belt-Dusebout Second cancer risk following testicular cancer A follow-up study of 1,909 patients J Clin Oncol 11 1993 415 424
60. G.K. Jacobsen, A. Mellemgaard, S.A. Engelholm Increased incidence of sarcoma in patients treated for testicular seminoma Eur J Cancer 5 1993 664 668
61. C.R. Nichols, B.J. Roth, N. Heerema Hematologic neoplasia associated with primary mediastinal germ-cell tumors N Engl J Med 322 1990 1425 1429
62. C.R. Nichols, E.S. Breeden, P.J. Loehrer Secondary leukemia associated with a conventional dose of etoposide Review of serial germ cell tumor protocols J Natl Cancer Inst 85 1993 36 40
63. J. Pedersen-Bjergaard, P. Philip, S.O. Larsen Therapy related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series Leukemia 7 1993 1975 1986
64. E. Segelov, D. Raghavan, H. Kronenberg Acute leukemia following chemotherapy including etoposide for testicular carcinoma Aust N Z J Med 23 1993 718 719
65. P.M. Petersen, S.W. Hansen, A. Giwercman Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer Ann Oncol 5 1994 355 358
66. R.E. Drasga, L.H. Einhorn, S.D. Williams Fertility after chemotherapy for testicular cancer J Clin Oncol 1 1983 179 183
67. S.P. Leitner, G.J. Bosl, D. Bajorunas Gonadal dysfunction in patients treated for metastatic germ-cell tumors J Clin Oncol 4 1986 1500 1505
68. P.V. Hansen, H. Trykker, P.E. Helkjoer Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy J Natl Cancer Inst 81 1989 1246 1250
69. D. Raghavan Follow up of the patient with testicular cancer F.S. Johnson K. Virgo Cancer patient follow up 1995 Mosby St. Louis (MO) 408 415